Prediction of Lifetime and 10-Year Risk of Cancer in Individual Patients With Established Cardiovascular Disease
Cilie C. van ’t Klooster, Paul M. Ridker, Nancy R. Cook, Joachim G.J.V. Aerts, Jan Westerink, Folkert W. Asselbergs, Yolanda van der Graaf, Frank L.J. Visseren and on behalf of the UCC-SMART Study Group
External Calibration in the CANTOS Trial Population of Cancer Models Before and After Recalibration
Calibration plots are shown of the predicted versus observed 4-year risk of total (A), colorectal (B), and lung cancer (C) in the CANTOS (Canakinumab Anti-Inflammatory Thrombosis Outcomes Study) study population, before and after recalibration. The study population is divided into quantiles based on the predicted risk, and ordered according to increasing predicted risk. The diagonal dotted line represents perfect calibration.